Abstract
Hematological malignancies constitute a heterogeneous group of conditions. Residual minimal disease (RMS) refers to the presence of haematological malignancy in patients who are in remission if conventional pathological analyzes are used. RMS has been shown to have prognostic significance in conditions such as: acute myeloid leukemia, chronic myeloid leukemia, multiple myeloma, and acute and chronic lymphoblastic leukemia. Ultrasensitive detection of this condition could allow a better risk stratification and open opportunities for early therapeutic interventions. In the following article there will be a brief review about the prognostic importance of RMS in different hematologic malignancies.
| Translated title of the contribution | Residual minimal disease: Breaking the paradigm of complete remission |
|---|---|
| Original language | English |
| Pages (from-to) | 21-32 |
| Number of pages | 12 |
| Journal | Revista Cubana de Hematologia, Inmunologia y Hemoterapia |
| Volume | 34 |
| Issue number | 1 |
| State | Published - 1 Jan 2018 |
Bibliographical note
Publisher Copyright:© 2018, Editorial Ciencias Medicas. All rights reserved.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Types Minciencias
- Artículos de investigación con calidad Q4
Fingerprint
Dive into the research topics of 'Residual minimal disease: Breaking the paradigm of complete remission'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver